Stay updated on CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Sign up to get notified when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.

Latest updates to the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page
- ChecktodayChange DetectedThe study details page now shows recruitment is closed ('No longer looking for participants'), and the 'Intervention/Treatment' label has been standardized. New help/navigation sections—How to Read a Study Record, Common Questions, and How to Join a Study—were added.SummaryDifference0.3%

- Check7 days agoChange DetectedThe page shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a version update rather than changes to study information.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page’s revision label changed from v3.5.3 to v3.5.4, indicating a minor metadata update to the page.SummaryDifference0.0%

- Check36 days agoChange DetectedThe Taiwan site entry in the study's locations list now uses 'Taoyuan City, Taiwan' instead of 'Taoyuan, Taiwan', clarifying the exact city designation used for that site.SummaryDifference0.0%

- Check50 days agoChange DetectedThe footer revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check86 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to CAB-ROR2-ADC: Phase 1/2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-ROR2-ADC: Phase 1/2 Clinical Trial page.